Skip to main content
TipRanks
Go Ultimate75% OFF

Caribou Biosciences (CRBU) Ratios

1,001 Followers

Caribou Biosciences Ratios

CRBU's free cash flow for Q3 2026 was $-22.54M. For the 2026 fiscal year, CRBU's free cash flow was decreased by $-19.00K and operating cash flow was $-22.52M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio5.717.1611.979.2515.15
Quick Ratio5.717.1611.979.2515.15
Cash Ratio0.490.531.812.079.31
Solvency Ratio-2.72-2.41-1.54-1.31-1.21
Operating Cash Flow Ratio-4.37-4.51-3.30-3.23-1.26
Short-Term Operating Cash Flow Coverage0.000.000.000.00-125.56
Net Current Asset Value$ 92.04M$ 159.01M$ 275.03M$ 187.35M$ 336.66M
Leverage Ratios
Debt-to-Assets Ratio0.160.080.060.070.00
Debt-to-Equity Ratio0.220.100.070.090.00
Debt-to-Capital Ratio0.180.090.070.080.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.441.241.171.241.14
Debt Service Coverage Ratio0.000.000.000.00-246.93
Interest Coverage Ratio0.000.000.000.00-8372.38
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.290.290.370.460.00
Net Debt to EBITDA-0.10-0.070.210.323.66
Profitability Margins
Gross Profit Margin67.34%60.71%89.78%73.71%89.75%
EBIT Margin-1332.33%-1492.04%-336.63%-717.28%-693.83%
EBITDA Margin-1299.67%-1452.74%-326.40%-691.00%-683.58%
Operating Profit Margin-1220.49%-1667.16%-336.63%-768.17%-697.84%
Pretax Profit Margin-1332.33%-1492.04%-295.49%-717.28%-693.92%
Net Profit Margin-1327.40%-1491.95%-296.05%-717.79%-697.26%
Continuous Operations Profit Margin-1327.40%-1491.95%-296.05%-717.79%-697.26%
Net Income Per EBT99.63%99.99%100.19%100.07%100.48%
EBT Per EBIT109.16%89.50%87.78%93.38%99.44%
Return on Assets (ROA)-84.47%-47.59%-23.62%-26.60%-15.13%
Return on Equity (ROE)-121.24%-58.95%-27.71%-33.04%-17.26%
Return on Capital Employed (ROCE)-90.82%-58.95%-28.73%-30.78%-16.08%
Return on Invested Capital (ROIC)-89.77%-58.65%-28.65%-30.70%-16.07%
Return on Tangible Assets-84.47%-47.59%-23.62%-26.60%-15.13%
Earnings Yield-99.75%-103.83%-24.13%-26.04%-7.36%
Efficiency Ratios
Receivables Turnover3.753.078.932.971.18
Payables Turnover0.631.591.133.180.25
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.460.250.850.401.96
Asset Turnover0.060.030.080.040.02
Working Capital Turnover Ratio0.070.040.130.050.05
Cash Conversion Cycle-481.65-111.40-282.218.02-1171.08
Days of Sales Outstanding97.44118.7340.85122.91308.95
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding579.09230.13323.06114.881480.03
Operating Cycle97.44118.7340.85122.91308.95
Cash Flow Ratios
Operating Cash Flow Per Share-1.19-1.53-1.26-1.50-0.54
Free Cash Flow Per Share-1.20-1.60-1.42-1.60-0.59
Dividend Paid and CapEx Coverage Ratio-81.67-21.25-8.03-14.09-10.42
Capital Expenditure Coverage Ratio-81.67-21.25-8.03-14.09-10.42
Operating Cash Flow Coverage Ratio-4.08-5.22-3.44-3.28-125.56
Operating Cash Flow to Sales Ratio-9.95-13.83-2.71-6.57-3.39
Free Cash Flow Yield-75.66%-100.77%-24.80%-25.51%-3.92%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.00-0.96-4.14-3.84-13.59
Price-to-Sales (P/S) Ratio13.3114.3712.2727.5794.75
Price-to-Book (P/B) Ratio1.220.571.151.272.34
Price-to-Free Cash Flow (P/FCF) Ratio-1.32-0.99-4.03-3.92-25.52
Price-to-Operating Cash Flow Ratio-1.34-1.04-4.53-4.20-27.96
Price-to-Earnings Growth (PEG) Ratio0.28-0.050.26-0.081.30
Enterprise Value Multiple-1.13-1.06-3.54-3.67-10.20
Enterprise Value163.36M153.80M398.86M351.24M669.21M
EV to EBITDA-1.13-1.06-3.54-3.67-10.20
EV to Sales14.6415.3911.5725.3669.72
EV to Free Cash Flow-1.45-1.06-3.80-3.61-18.78
EV to Operating Cash Flow-1.47-1.11-4.28-3.86-20.58
Tangible Book Value Per Share1.312.804.994.956.44
Shareholders’ Equity Per Share1.312.804.994.956.44
Tax and Other Ratios
Effective Tax Rate0.000.00-0.00-0.00-0.00
Revenue Per Share0.120.110.470.230.16
Net Income Per Share-1.59-1.65-1.38-1.64-1.11
Tax Burden1.001.001.001.001.00
Interest Burden1.001.000.881.001.00
Research & Development to Revenue9.8113.023.255.945.44
SG&A to Revenue3.404.651.122.740.00
Stock-Based Compensation to Revenue1.141.670.400.000.36
Income Quality0.750.930.910.910.49

Currency in USD